You are here: Home » PTI Stories » National » News
Business Standard

Zydus partners Medicure to launch cholesterol drug in US

Press Trust of India  |  New Delhi 

Drug firm has entered into a definitive agreement with US-based to commercialise its new in the US.

"The launch of ZYPITAMAG, which is used to manage cholesterol levels, marks the first branded product launch for Zydus in the US," the company said in a regulatory filing.

said as part of this agreement, it will hold the new drug application (NDA) and Medicure will be responsible for the sales and marketing of ZYPITAMAG.

has entered into an agreement with Medicure International Inc, a subsidiary of

ZYPITAMAG has been approved in strengths of 1 mg, 2 mg and 4 mg.

Shares of the company's listed entity were trading 0.13 per cent up at Rs 381.05 on the

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Thu, March 08 2018. 11:30 IST